相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: Results from the PPP-Botnia Study
Antti-Jussi Pyykkonen et al.
ANNALS OF MEDICINE (2012)
The lipid profiles in Japanese patients with schizophrenia treated with antipsychotic agents
Junzo Watanabe et al.
GENERAL HOSPITAL PSYCHIATRY (2012)
A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
T. Scott Stroup et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Depression and Risk of Stroke Morbidity and Mortality A Meta-analysis and Systematic Review
An Pan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: A population-based study
Chun-Hui Liao et al.
SCHIZOPHRENIA RESEARCH (2011)
Overweight, Obesity, and Depression A Systematic Review and Meta-analysis of Longitudinal Studies
Floriana S. Luppino et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Bidirectional Association Between Depression and Type 2 Diabetes Mellitus in Women
An Pan et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
The Impact of Serious Mental Illness on Health and Healthcare
M. J. Viron et al.
PSYCHOSOMATICS (2010)
National Patterns in Antidepressant Medication Treatment
Mark Olfson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population
Erica J. Duncan et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
Major Depression as a Risk Factor for High Blood Pressure: Epidemiologic Evidence From a National Longitudinal Study
Scott B. Patten et al.
PSYCHOSOMATIC MEDICINE (2009)
Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
Jayendra K. Patel et al.
SCHIZOPHRENIA RESEARCH (2009)
Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizoaffective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
Linmarie Sikich et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
John McGrath et al.
EPIDEMIOLOGIC REVIEWS (2008)
The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults
Tara W. Strine et al.
GENERAL HOSPITAL PSYCHIATRY (2008)
Dyslipidemia independent of body mass in anti psychotic-treated patients under real-life conditions
Astrid B. Birkenaes et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community
Paul Mackin et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
A clinical study of the association of antipsychotics with hyperlipidemia
Jose de Leon et al.
SCHIZOPHRENIA RESEARCH (2007)
Depressive symptoms and risk of stroke - The Framingham Study
Kimberly J. Salaycik et al.
STROKE (2007)
Insulin resistance and atherosclerosis
Clay F. Semenkovich
JOURNAL OF CLINICAL INVESTIGATION (2006)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
JP McEvoy et al.
SCHIZOPHRENIA RESEARCH (2005)
Schizophrenia and increased risks of cardiovascular disease
CH Hennekens et al.
AMERICAN HEART JOURNAL (2005)
Role of depression and inflammation in incident coronary heart disease events
D Shimbo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction
LJ Tata et al.
HEART (2005)
HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Diet, diabetes and schizophrenia: review and hypothesis
M Peet
BRITISH JOURNAL OF PSYCHIATRY (2004)
Consensus development conference on antipsychotic drugs and obesity and diabetes
DIABETES CARE (2004)
Use of metabolic markers to identify overweight individuals who are insulin resistant
T McLaughlin et al.
ANNALS OF INTERNAL MEDICINE (2003)
Patients on atypical antipsychotic drugs - Another high-risk group for type 2 diabetes
MEJ Lean et al.
DIABETES CARE (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Hyperlipidemia - Side-effect of the treatment with an atypical antipsychotic (Zotepine)?
T Wetterling
PSYCHIATRISCHE PRAXIS (2002)
Physical consequences of schizophrenia and its treatment - The metabolic syndrome
MCM Ryan et al.
LIFE SCIENCES (2002)
Antipsychotic-induced weight gain and therapeutic response: A differential association
P Czobor et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: Metabolic outcomes after 1 year
JM Meyer
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Quetiapine-associated hyperglycemia and hypertriglyceridemia
SE Domon et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Hyperglycemia and hypertriglyceridemia secondary to olanzapine
SE Domon et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate
KR Fontaine et al.
PSYCHIATRY RESEARCH (2001)
Insulin and leptin levels in patients with schizophrenia or related psychoses - a comparison between different antipsychotic agents
KI Melkersson et al.
PSYCHOPHARMACOLOGY (2001)
Olanzapine and hypertriglyceridemia
M Nguyen et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
TP George et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
U Ösby et al.
SCHIZOPHRENIA RESEARCH (2000)
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
DC Henderson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
